Keyphrases
Alzheimer's Disease
76%
Autosomal Dominant Alzheimer's Disease
48%
Cerebrospinal Fluid
30%
Induced Pluripotent Stem Cells (iPSCs)
21%
Frontotemporal Dementia
19%
Mutation Carriers
17%
Neurodegeneration
17%
Presenilin
15%
Tau Pathology
14%
Sporadic Alzheimer's Disease
14%
Tauopathy
14%
Astrocytes
12%
Dominantly Inherited Alzheimer Network
12%
Alzheimer's Disease Risk
12%
Symptom Onset
11%
Neurodegenerative Diseases
11%
Triggering Receptor Expressed on Myeloid Cells 2 (TREM2)
11%
Cognitive Decline
10%
Non-carriers
10%
Microglia
10%
Alzheimer's Disease Pathology
10%
Genome-wide Association Study
9%
Dominantly Inherited Alzheimer's Disease
9%
Phosphorylated tau
8%
Disease Progression
8%
Superoxide Dismutase 1 (SOD1)
8%
Frontotemporal Lobar Degeneration
8%
Stem Cell Models
8%
Late-onset Alzheimer's Disease
7%
Autosomal Dominant
7%
Disease-causing mutations
7%
Apolipoprotein E
7%
Amyotrophic Lateral Sclerosis
7%
MAPT mutation
7%
Progressive Supranuclear Palsy
6%
Tau Protein
6%
Alzheimer's Disease Brain
6%
Neurofilament Light (NF-L)
5%
Dementia
5%
Risk Variant
5%
Amyloid Precursor Protein
5%
Total tau
5%
Genetic Variants
5%
Pathogenic Variants
5%
PSEN2
5%
Neuroscience
Alzheimer's Disease
100%
Amyloid Protein
28%
Stem Cell
19%
Frontotemporal Dementia
18%
Neurodegeneration
17%
Tauopathy
16%
Astrocyte
14%
Tau Protein
8%
Genome-Wide Association Study
8%
Microglia
7%
Progressive Supranuclear Palsy
7%
Neurodegenerative Disorder
7%
Gene Expression
7%
Positron Emission Tomography
5%
Microtubule
5%
Apolipoprotein E
5%
Clinical Dementia Rating
5%
Biochemistry, Genetics and Molecular Biology
Tau
48%
Autosomal Dominant Inheritance
34%
Amyloid Protein
23%
Genetics
19%
Induced Pluripotent Stem Cell
10%
PSEN1
9%
Presenilin
9%
Tau Protein
9%
TREM2
9%
Genome-Wide Association Study
8%
Microglia
7%
Stem Cell
7%
Genetic Divergence
7%
Genetic Risk
7%
Single Nucleotide Polymorphism
7%
Astrocyte
6%
Observational Study
6%
Magnetic Resonance Imaging
5%
Blood Plasma
5%
PSEN2
5%
Proteomics
5%
Human Induced Pluripotent Stem Cell
5%